Zhou P,Yang X-L,Wang X-G,Hu B,Zhang L,Zhang W .2020 .A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798) : 270-3.
Yin Y,Wunderink RG .2018 .MERS, SARS and other coronaviruses as causes of pneumonia. Respirology, 23 : 130-137.
Hui DS,Madani I Azhar E,Ntoumi TA,Kock F,Dar R,O R .2020 .The continuing 2019-ncov epidemic threat of novel coronaviruses to Global Health - the latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases, 91 : 264-6.
Baden LR,El Sahly HM,Essink B,Kotloff K,Frey S,Novak R,SARS-CoV- R,Vaccine. N Engl J Med R .2021 .Efficacy and Safety of the mRNA-. , 384(5) : 403-416.
Vallianou NG,Tsilingiris D,Christodoulatos GS,Karampela I,Dalamaga M .2021 .Anti-viral treatment for SARSCoV-2 infection: A race against time amidst the ongoing pandemic. Metabol Open, 10 : 100096.
Barda N,Dagan N,Ben-Shlomo Y,Kepten E,Waxman J,Ohana R .2021 .. Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting. N Engl J Med, (12) : 1078-1090.
Choi A,Ibañez LI,Strohmeier S,Krammer F,GarcíaSastre A,Schotsaert M .2020 .Non-sterilizing, InfectionPermissive Vaccination with Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity from Cellular to Humoral Cross-Reactive Immune Responses. Front Immunol, 01166(11) : 1166.
Misu T,Kortepeter CM,Muñoz MA,Wu E,Dal Pan GJ .2018 .An Evaluation of “Drug Ineffective” Postmarketing Reports in Drug Safety Surveillance. Drugs Real World Outcomes, 5(2) : 91-99.
Di Fusco M,Moran MM,Cane A,Curcio D,Khan F,Malhotra D .2021 .Evaluation of COVID-19 vaccine breakthrough infections among immunocompromised patients fully vaccinated with BNT162b2. J Med Econ, 24(1) : 1248-1260.
Ul Munamm SA,Nadeem I,Mahdi N,Saqlain M,Rana ZK,Khatana UF,J R Coll Physicians Edin UF .2022 .Comparative analysis of mRNA and inactivated COVID-19 vaccines: A study from Faisalabad district of Pakistan. , 52(3) : 240-246.
Ben Fredj S,Ghammem R,Zammit N,Maatouk A,Hadded N,Laadhari H,Ben Fredj Eur J Public Health Sihem .2022 .Characteristics of COVID19 cases with breakthrough infection in the governorate of Sousse. , 32(Suppl 3) : 451-2.
Abbas S,Abbas B,Amir S,Wajahat M .2021 .Evaluation of adverse effects with COVID-19 vaccination in Pakistan. Pak J Med Sci, 37(7) : 1959-1964.
Cohen KW,Linderman SL,Moodie Z,Czartoski J,Lai L,Mantus G,Norwood C .2021 .Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells. Cell Rep Med, 100354(7) : 100354.
Brunelli SM,Sibbel S,Karpinski S,Marlowe G,Walker AG,Giullian J .2022 .Comparative Effectiveness of mRNA-based BNT162b2 Vaccine versus Adenovirus Vector-Based Ad26.COV2. S Vaccine for the Prevention of COVID-19 among Dialysis Patients. J Am Soc Nephrol, 33(4) : 688-697.
Galmiche S,Luong Nguyen LB,Tartour E,de Lamballerie X,Wittkop L,Loubet P .2022 .Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review. Clin Microbiol Infect, 28(2) : 163-177.
Mahase E .2022 .Vaccinated people are less likely to get long covid, review finds. BMJ, 16 : 376.